Corporate Interest in Prediction Markets Persists Amid Regulatory Uncertainty Retirement Planning With 500k Strategies to Mitigate Outliving Savings Risk UK Biotech Startup BioOrbit Launches DrugCrystallisation Technology to International Space Station Charter Communications Proposes Improved Buyout Terms for Liberty Broadband Huawei Unveils New Chip Design Method Amid US Restrictions Plans Smartphone Chips for Fall Constellation CEG Commences Operations at Pin Oak Energy Facility RDNW Q1 2026 Earnings NarrowerThanExpected Loss Exceeds Analyst Estimates SWVL Q4 2022 Earnings Narrower Loss Beats Expectations Stock Rises LADR Q1 2026 Earnings EPS Misses Estimates Stock Rises 15 GKOS Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Shares AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress ICU Q1 2026 Earnings WiderthanExpected Loss as Company Remains PreRevenue Sachem Capital Notes SCCF Hold Steady Near Par as Market Awaits Direction Penguin Solutions Inc PENG Rallies 327 as Buyers Test Critical Resistance Near 577 Elicio Therapeutics ELTX Holds Near Resistance as Therapeutic Pipeline Momentum Builds EPower Inc EPOW Edges Higher Tests Key Resistance at 070 Chubb Limited CB Slips 148 as Insurance Sector Faces Headwinds Key Support Levels in Focus UBS Adopts Cautious Stance on Bath Body Works BBWI Ahead of Upcoming Earnings NTZ Q4 2011 Earnings EPS Misses Expectations Amid Challenging Environment Manchester United Shares Slip Amid Performance Concerns Bipartisan Home Affordability Bill Passes House Aims to Boost Construction and Curb Corporate Buying CBUS Q1 2026 Earnings Narrowed Loss Per Share Beats Estimates Despite Negative Stock Reaction Samsung Semiconductor Workers Poised for Record Bonuses Under Tentative Strike Settlement Intuit Announces 17 Workforce Reduction Amid Slowing Growth and AI Disruption Concerns Knightscope Inc KSCP Q1 2026 Earnings WiderthanExpected Loss Amid Strategic Uncertainty Wall Street Gains as Chip Stocks Surge Ahead of Nvidia Earnings Report Adagene Q2 2025 Earnings Clinical Progress Overshadows EPS Miss Shares Jump